Zenas BioPharma, Inc. Common Stock (ZBIO) — Defensive Interval Ratio
Zenas BioPharma, Inc. Common Stock (ZBIO) has a Defensive Interval Ratio of 2481 days as of June 2026. Defensive assets of $447.35 Million (cash $-, short-term investments $446.55 Million, receivables $800.00K) cover 2481 days of daily cash needs of $180.32K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Zenas BioPharma, Inc. Common Stock Defensive Interval Ratio (2023–2025)
This chart shows how Zenas BioPharma, Inc. Common Stock's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of June 2026, the ratio stands at 2481 days, meaning defensive assets of $447.35 Million can fund 2481 days of operations without new revenue. For the complete balance sheet picture, see Zenas BioPharma, Inc. Common Stock (ZBIO) total assets.
Annual Defensive Interval Ratio for Zenas BioPharma, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for Zenas BioPharma, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Zenas BioPharma, Inc. Common Stock (ZBIO) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1355 days | $232.55 Million | $171.64K/day | $- | $232.55 Million | ▲ +1157 days |
| 2024 | 198 days | $31.02 Million | $156.96K/day | $- | $31.02 Million | ▲ +198 days |
| 2023 | 0 days | $0.00 | $63.72K/day | $- | $0.00 | — |